These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 29771781)

  • 1. Lack of Virological Suppression Among Young HIV-Positive Adults in Botswana.
    Novitsky V; Gaolathe T; Mmalane M; Moyo S; Chakalisa U; Yankinda EK; Marukutira T; Holme MP; Sekoto T; Gaseitsiwe S; Musonda R; van Widenfelt E; Powis KM; Khan N; Dryden-Peterson S; Bennett K; Wirth KE; Tchetgen ET; Bachanas P; Mills LA; Lebelonyane R; El-Halabi S; Makhema J; Lockman S; Essex M
    J Acquir Immune Defic Syndr; 2018 Aug; 78(5):557-565. PubMed ID: 29771781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population uptake of HIV testing, treatment, viral suppression, and male circumcision following a community-based intervention in Botswana (Ya Tsie/BCPP): a cluster-randomised trial.
    Wirth KE; Gaolathe T; Pretorius Holme M; Mmalane M; Kadima E; Chakalisa U; Manyake K; Matildah Mbikiwa A; Simon SV; Letlhogile R; Mukokomani K; van Widenfelt E; Moyo S; Bennett K; Leidner J; Powis KM; Lebelonyane R; Alwano MG; Jarvis J; Dryden-Peterson SL; Kgathi C; Moore J; Bachanas P; Raizes E; Abrams W; Block L; Sento B; Novitsky V; El-Halabi S; Marukutira T; Mills LA; Sexton C; Pals S; Shapiro RL; Wang R; Lei Q; DeGruttola V; Makhema J; Essex M; Lockman S; Tchetgen Tchetgen EJ
    Lancet HIV; 2020 Jun; 7(6):e422-e433. PubMed ID: 32504575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botswana's progress toward achieving the 2020 UNAIDS 90-90-90 antiretroviral therapy and virological suppression goals: a population-based survey.
    Gaolathe T; Wirth KE; Holme MP; Makhema J; Moyo S; Chakalisa U; Yankinda EK; Lei Q; Mmalane M; Novitsky V; Okui L; van Widenfelt E; Powis KM; Khan N; Bennett K; Bussmann H; Dryden-Peterson S; Lebelonyane R; El-Halabi S; Mills LA; Marukutira T; Wang R; Tchetgen EJ; DeGruttola V; Essex M; Lockman S;
    Lancet HIV; 2016 May; 3(5):e221-30. PubMed ID: 27126489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-sectional estimates revealed high HIV incidence in Botswana rural communities in the era of successful ART scale-up in 2013-2015.
    Moyo S; Gaseitsiwe S; Mohammed T; Pretorius Holme M; Wang R; Kotokwe KP; Boleo C; Mupfumi L; Yankinda EK; Chakalisa U; van Widenfelt E; Gaolathe T; Mmalane MO; Dryden-Peterson S; Mine M; Lebelonyane R; Bennett K; Leidner J; Wirth KE; Tchetgen Tchetgen E; Powis K; Moore J; Clarke WA; Lockman S; Makhema JM; Essex M; Novitsky V
    PLoS One; 2018; 13(10):e0204840. PubMed ID: 30356287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High HIV-1 RNA Among Newly Diagnosed People in Botswana.
    Novitsky V; Prague M; Moyo S; Gaolathe T; Mmalane M; Yankinda EK; Chakalisa U; Lebelonyane R; Khan N; Powis KM; Widenfelt E; Gaseitsiwe S; Dryden-Peterson SL; Holme MP; De Gruttola V; Bachanas P; Makhema J; Lockman S; Essex M
    AIDS Res Hum Retroviruses; 2018 Mar; 34(3):300-306. PubMed ID: 29214845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progress towards the UNAIDS 95-95-95 targets in the Fifth Botswana AIDS Impact Survey (BAIS V 2021): a nationally representative survey.
    Mine M; Stafford KA; Laws RL; Marima R; Lekone P; Ramaabya D; Makhaola K; Patel HK; Mapondera P; Wray-Gordon F; Agbakwuru C; Okui L; Matroos S; Onyadile E; Ngidi J; Abimiku A; Bagapi K; Nkomo B; Bodika SM; Kim KJ; Moloney M; Mitchell A; Ehoche A; Ussery FL; Hong SY; Keipeile S; Matlhaga M; Mathumo R; Selato R; Charurat ME; Voetsch AC
    Lancet HIV; 2024 Apr; 11(4):e245-e254. PubMed ID: 38467135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response to zidovudine/didanosine-containing combination antiretroviral therapy among HIV-1 subtype C-infected adults in Botswana: two-year outcomes from a randomized clinical trial.
    Bussmann H; Wester CW; Thomas A; Novitsky V; Okezie R; Muzenda T; Gaolathe T; Ndwapi N; Mawoko N; Widenfelt E; Moyo S; Musonda R; Mine M; Makhema J; Moffat H; Essex M; Degruttola V; Marlink RG
    J Acquir Immune Defic Syndr; 2009 May; 51(1):37-46. PubMed ID: 19282782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved virologic outcomes over time for HIV-infected patients on antiretroviral therapy in a cohort from Rio de Janeiro, 1997-2011.
    Martin DA; Luz PM; Lake JE; Clark JL; Veloso VG; Moreira RI; Cardoso SW; Klausner JD; Grinsztejn B
    BMC Infect Dis; 2014 Jun; 14():322. PubMed ID: 24919778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low rates of nucleoside reverse transcriptase inhibitor and nonnucleoside reverse transcriptase inhibitor drug resistance in Botswana.
    Moyo S; Gaseitsiwe S; Zahralban-Steele M; Maruapula D; Nkhisang T; Mokaleng B; Mohammed T; Ditlhako TR; Bareng OT; Mokgethi TP; van Widenfelt E; Pretorius-Holme M; Mine MO; Raizes E; Yankinda EK; Wirth KE; Gaolathe T; Makhema JM; Lockman S; Essex M; Novitsky V
    AIDS; 2019 May; 33(6):1073-1082. PubMed ID: 30946161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successes and gaps in the HIV cascade of care of a high HIV prevalence setting in Zimbabwe: a population-based survey.
    Conan N; Coulborn RM; Simons E; Mapfumo A; Apollo T; Garone DB; Casas EC; Puren AJ; Chihana ML; Maman D
    J Int AIDS Soc; 2020 Sep; 23(9):e25613. PubMed ID: 32969602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Towards achieving the 90-90-90 HIV targets: results from the south African 2017 national HIV survey.
    Marinda E; Simbayi L; Zuma K; Zungu N; Moyo S; Kondlo L; Jooste S; Nadol P; Igumbor E; Dietrich C; Briggs-Hagen M
    BMC Public Health; 2020 Sep; 20(1):1375. PubMed ID: 32907565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. To achieve 95-95-95 targets we must reach men and youth: High level of knowledge of HIV status, ART coverage, and viral suppression in the Botswana Combination Prevention Project through universal test and treat approach.
    Lebelonyane R; Bachanas P; Block L; Ussery F; Alwano MG; Marukutira T; El Halabi S; Roland M; Abrams W; Ussery G; Miller JA; Lockman S; Gaolathe T; Holme MP; Hader S; Mills LA; Wirth K; Bock N; Moore J
    PLoS One; 2021; 16(8):e0255227. PubMed ID: 34375343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sexual behaviour among people with HIV according to self-reported antiretroviral treatment and viral load status.
    Lampe FC;
    AIDS; 2016 Jul; 30(11):1745-59. PubMed ID: 27045375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Level of viral suppression and the cascade of HIV care in a South African semi-urban setting in 2012.
    Jean K; Puren A; Cutler E; Singh B; Bouscaillou J; Rain-Taljaard R; Taljaard D; Gouws E; Lissouba P; Lewis DA; Peytavin G; Auvert B
    AIDS; 2016 Aug; 30(13):2107-16. PubMed ID: 27163707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Finding, treating and retaining persons with HIV in a high HIV prevalence and high treatment coverage country: Results from the Botswana Combination Prevention Project.
    Bachanas P; Alwano MG; Lebelonyane R; Block L; Behel S; Raizes E; Ussery G; Wang H; Ussery F; Pretorius Holme M; Sexton C; Pals S; Lasry A; Del Castillo L; Hader S; Lockman S; Bock N; Moore J
    PLoS One; 2021; 16(4):e0250211. PubMed ID: 33882092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The HIV care cascade for adolescents initiated on antiretroviral therapy in a health district of South Africa: a retrospective cohort study.
    Haghighat R; Toska E; Bungane N; Cluver L
    BMC Infect Dis; 2021 Jan; 21(1):60. PubMed ID: 33435861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV disease is associated with increased biomarkers of endothelial dysfunction despite viral suppression on long-term antiretroviral therapy in Botswana.
    Mosepele M; Mohammed T; Mupfumi L; Moyo S; Bennett K; Lockman S; Hemphill LC; Triant VA
    Cardiovasc J Afr; 2018 May/Jun 23; 29(3):155-161. PubMed ID: 29771268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of residual viraemia in patients on long-term suppressive antiretroviral therapy.
    Zheng L; Bosch RJ; Chan ES; Read S; Kearney M; Margolis DM; Mellors JW; Eron JJ; Gandhi RT;
    Antivir Ther; 2013; 18(1):39-43. PubMed ID: 22914318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of population-based HIV RNA levels in a rural east African setting using a fingerprick-based blood collection method.
    Jain V; Liegler T; Kabami J; Chamie G; Clark TD; Black D; Geng EH; Kwarisiima D; Wong JK; Abdel-Mohsen M; Sonawane N; Aweeka FT; Thirumurthy H; Petersen ML; Charlebois ED; Kamya MR; Havlir DV;
    Clin Infect Dis; 2013 Feb; 56(4):598-605. PubMed ID: 23243180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding the role of resilience resources, antiretroviral therapy initiation, and HIV-1 RNA suppression among people living with HIV in South Africa: a prospective cohort study.
    Katz IT; Bogart LM; Dietrich JJ; Leslie HH; Iyer HS; Leone D; Magidson JF; Earnshaw VA; Courtney I; Tshabalala G; Fitzmaurice GM; Orrell C; Gray G; Bangsberg DR
    AIDS; 2019 Jun; 33 Suppl 1(Suppl 1):S71-S79. PubMed ID: 31397725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.